Quantitative stability of MGMT promoter methylation in recurrent glioma and implications for temozolomide rechallenge.

Noren H, Pelofsky G, Suffren B, Mittelman L, Yohn C, Twyman A, Febres-Aldana CA, Abramyan A, Sertil A, D'Amico RS, Sherman JH, Vojnic M

Open source

DOI: 10.1007/s11060-026-05778-y
Published: 2026 Sep 16
Container: Journal of neuro-oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11060-026-05778-y,
  title = {Quantitative stability of MGMT promoter methylation in recurrent glioma and implications for temozolomide rechallenge.},
  author = {Noren H and Pelofsky G and Suffren B and Mittelman L and Yohn C and Twyman A and Febres-Aldana CA and Abramyan A and Sertil A and D'Amico RS and Sherman JH and Vojnic M},
  year = {2026},
  journal = {Journal of neuro-oncology},
  doi = {10.1007/s11060-026-05778-y},
  url = {https://doi.org/10.1007/s11060-026-05778-y}
}

RIS

TY  - JOUR
TI  - Quantitative stability of MGMT promoter methylation in recurrent glioma and implications for temozolomide rechallenge.
AU  - Noren H
AU  - Pelofsky G
AU  - Suffren B
AU  - Mittelman L
AU  - Yohn C
AU  - Twyman A
AU  - Febres-Aldana CA
AU  - Abramyan A
AU  - Sertil A
AU  - D'Amico RS
AU  - Sherman JH
AU  - Vojnic M
PY  - 2026
JO  - Journal of neuro-oncology
DO  - 10.1007/s11060-026-05778-y
UR  - https://doi.org/10.1007/s11060-026-05778-y
ER  -

APA

H, N., G, P., B, S., L, M., C, Y., A, T., CA, F., A, A., A, S., RS, D., JH, S., & M, V. (2026). Quantitative stability of MGMT promoter methylation in recurrent glioma and implications for temozolomide rechallenge.. Journal of neuro-oncology. https://doi.org/10.1007/s11060-026-05778-y

Source records

pubmed · retrieved 2026-09-25T20:59:43.707Z